Beacon is delighted after launching Multiple Tyrosine Kinase Inhibitor (TKI), Pazonix that is only for the treatment of renal cell carcinoma

Beacon Medicare Limited, a number one oncology company in Bangladesh, has launched Pazonix in tablet form under the generic of Pazopanib, an anti-cancer drug, only for export purpose in the world market. Pazonix ( pazopanib) is one of the most advanced & latest drug for the treatment of Renal Cell Carcinoma. This is the global [...]